Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia

Manhattan Hematol Oncol Associates, New York

Clinical Research Alliance, Lake Success

NYU Langone Long Island, Mineola

New York Bld And Cancer Specialists, Port Jefferson

SUNY Upstate Medical Center, Syracuse

UPMC, Pittsburgh

Care Access Research, Easton

Thomas Jefferson University, Philadelphia

Virginia Cancer Specialists, Gainesville

Virginia Cancer Institute, Richmond

Virginia Oncology Associates, Norfolk

Wake Forest Uni Health Sci, Winston-Salem

University of North Carolina, Chapel Hill

Duke University Medical Center, Durham

Novant Health Heart Vas Inst, Charlotte

Bon Secours Cancer Center, Greenville

City Of Hope Atlanta, Atlanta

Northwest Georgia Oncology Center, Marietta

Emory University School of Medicine Winship Cancer Institute, Atlanta

Augusta University Georgia, Augusta

Baptist MD Anderson Cancer Center, Jacksonville

Florida Cancer Specialists-North, St. Petersburg

Florida Cancer Specialists, Fort Myers

Florida Cancer Specialists East, Stuart

Sarah Cannon Research Institute, Nashville

Jackson Onc Associates, Jackson

University of Kentucky, Lexington

Franciscan Health Indianapolis, Indianapolis

James Cancer Hospital and Solove Research Institute Ohio State, Columbus

Gabrail Cancer Center, Canton

Hematology Oncology Care, Cincinnati

Investigative Clinicl Rsrch of Indi, Indianapolis

Holden Comp Can Cent Quad Cities U, Iowa City

Medical College of Wisconsin, Milwaukee

Dean Health System, Madison

Avera Cancer, Sioux Falls

St Vincent Frontier Cancer Center, Billings

Siteman Cancer Center, St Louis

University Missouri Ellis Fischel Cancer Center, Columbia

Wichita Community Clcl Onco Program, Wichita

Nebraska Hematology Oncology P C, Lincoln

Louisiana State University, Shreveport

Texas Oncology, Dallas

Texas Oncology Northeast Texas, Tyler

Ctr For Cancer And Blood Disorders, Fort Worth

Houston Methodist Hospital, Houston

Univ of TX MD Anderson Cancer Cntr, Houston

Texas Oncology P A, Austin

Mays Cancer Center, San Antonio

Texas Oncology San Antonio, San Antonio

Rocky Mountain Cancer Centers, Boulder

Huntsman Cancer Institute, Salt Lake City

Community Cancer Trials of Utah, Ogden

City of Hope Phoenix, Scottsdale

USO Arizona Oncology, Tucson

UNM, Albuquerque

Hackensack Meridian Health, Edison

UCLA, Los Angeles

Onco Inst of Hope and Innovation, Cerritos

City of Hope National Medical, Duarte

Virginia K Crosson Cancer Center, Fullerton

UCSF Fresno Internal Medicine, Fresno

Alta Bates Summit Medical Center, Oakland

Oregon Health Sciences University, Portland

VA Puget Sound Health Care System, Seattle

Fred Hutch Cancer Research, Seattle

Northwest Medical Specialties, Tacoma

Alaska Oncology and Hematology, Anchorage

University of Alabama at Birmingham, Birmingham

Lundquist Inst BioMed at Harbor, Torrance

Yale University School Of Medicine, New Haven

The Stamford Hospital, Stamford

Dana Farber Cancer Center, Boston

Henry Ford Hospital, Detroit

Dartmouth Hitchcock Medical Center, Lebanon

Care Access Research Clifton, Clifton

Hackensack University Medical Ctr, Hackensack

Rutgers Cancer Institute of NJ, New Brunswick

Mt Sinai Medical Center, New York

SUNY Stony Brook Medical Oncology, Stony Brook